Stock earnings page

REPYY (REPYY)

Track the next or latest earnings date for REPYY, review consensus estimates, and see cached AI analysis for recent quarterly results.

View this earnings week Open in the app

Recent earnings news

Replimune Group (REPL) Shares Surge 127% After FDA Advisory Panel Support
gurufocus.com · 2026-07-31T13:31:06

On July 31, 2026, Replimune Group Inc (REPL) experienced a remarkable 127% surge in stock price following a favorable vote from an independent FDA advisory pane

REPL Stock Jumps As FDA Panel Backs Melanoma Drug - StocksToTrade
stockstotrade.com · 2026-07-31T12:34:08

Positive trial updates for Replimune Group Inc. could further extend its rally, as stocks have been trading up by 132.9 percent Key Takeaways Replimune’s melanoma therapy RP1 plus nivolumab won a favorable 10–3 vote from the FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee ...

Repligen Beats Q2 Earnings Estimates, Raises 2026 View, Stock Up
finance.yahoo.com · 2026-07-29T16:23:00

RGEN tops Q2 earnings and revenue estimates, lifts its 2026 revenue and EPS outlook, and sees shares jump after stronger-than-expected results.

Repsol Launches €500 Million Share Buyback and Capital Reduction - TipRanks.com
tipranks.com · 2026-07-24T13:46:58

Subscribe to TipRanks Smart Investor ... stock picks · Repsol ( (REPYY) ) just unveiled an update. Repsol’s board has approved an additional capital reduction via the cancellation of treasury shares to be acquired under a new share buyback program with a maximum net investment of 500 million euros. …

Repsol Completes €350 Million Buyback and Cancels 1.43% of Share Capital - The Globe and Mail
theglobeandmail.com · 2026-07-23T13:38:00

Its capital markets activity, including ... earnings per share and optimizing its shareholder base. The company operates under European market abuse regulations and regularly reports its share transactions to the Spanish National Securities Market Commission, reflecting its focus on transparency and…

Upcoming earnings date

Oct 29, 2026

Time not specified

Fiscal quarter: 2026-09-30

EPS estimate: N/A

Revenue estimate: N/A

Market cap: N/A

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week

Date	Quarter	Report window	EPS est.	Revenue est.
Oct 29, 2026	2026-09-30	Time not specified	N/A	N/A
Feb 19, 2026	2025-12-31	Time not specified	$0.76	N/A